|
|
|
40
|
A831AB
|
ARCOXIA 60MG TAB (MSD/STO) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
24.46
|
1.75
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831AB
|
ARCOXIA 60MG TAB (MSD) ETORICOXIB (C)
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
24.68
|
1.763
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
42
|
A831AB
|
ARCOXIA 60MG TAB (MSD) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
24.68
|
1.76
|
TAB
|
0
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
40
|
A831AD
|
ARCOXIA 90MG TAB (MSD/STO) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
27.18
|
1.94
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A831AD
|
ARCOXIA 90MG TAB (MSD) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
27.43
|
1.96
|
TAB
|
0
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
40
|
A831AF
|
ARCOXIA 120MG TAB (MSD/STO) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
48.52
|
3.47
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831AF
|
ARCOXIA 120MG TAB (MSD) ETORICOXIB (C)
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
49.01
|
3.5008
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
42
|
A831AF
|
ARCOXIA 120MG TAB (MSD) ETORICOXIB
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
49.01
|
3.50
|
TAB
|
0
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
41
|
A831DG
|
ARCOXIA 90MG TAB (MSD) ETORICOXIB (C)
|
ETORICOXIB
|
ARCOXIA
|
14'S
|
C
|
27.43
|
1.9591
|
TAB
|
0
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A831EW
|
ETOVAN 60MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
3X10
|
C
|
14.33
|
0.48
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A831EX
|
ETOVAN 90MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
2X15
|
C
|
11.04
|
0.37
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2022-07-13
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A831EX
|
ETOVAN 90MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
2X15
|
C
|
16.55
|
0.55
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-07-14
|
2024-03-31
|
Price Change
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-07-13
|
|
|
|
40
|
A831EY
|
ETOVAN 120MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
2X10
|
C
|
11.04
|
0.55
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831FU
|
ETORICOXIB 120MG CAP (MCP) (C)
|
ETORICOXIB
|
ETORICOXIB
|
3X10
|
C
|
11.06
|
0.3688
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FV
|
ETORICOXIB 60MG CAP (MCP) (C)
|
ETORICOXIB
|
ETORICOXIB
|
3X10
|
C
|
4.27
|
0.1423
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FW
|
ETORICOXIB 90MG CAP (MCP) (C)
|
ETORICOXIB
|
ETORICOXIB
|
3X10
|
C
|
5.63
|
0.1876
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|